photo

intellectual property

WHO, WIPO, WTO workshop on innovation in, and access to, COVID-19 technologies

Accessing and using information resources for the pandemic response


Virtual
28/02/2022 – 13:00 to 16:20

Welcome and Introduction - (13.00 – 13.10)

Mr. Antony Taubman

Director, Intellectual Property, Government Procurement and Competition Division, World Trade Organization, WTO

Moderator

Mr. Roger Kampf

Counsellor, Intellectual Property, Government Procurement and Competition Division, WTO

Session 1: COVID-19 Related Information Resources - (13.10 – 14.10)

Mr. Robert Koopman

Chief Economist and Director, Economic Research and Statistics Division, WTO

Dr. Taghreed Adam

Scientist, Department of Research for Health, Science Division, World Health Organization, WHO

Presentation

Ms. Erika Dueñas Loayza

Technical Officer, Department of Essential. Medicines and Health Products, WHO

Presentation

Ms. Amy Dietterich

Director, Global Challenges Division, Global Challenges and Partnerships Sector, World Intellectual Property Organization (WIPO)

Presentation

Mr. Christophe Mazenc

Director, Global Databases Division, Infrastructure and Platforms Sector, WIPO

Presentation

Mr. Georges Ghandour

Senior Counsellor, Development Agenda Coordination Division, Regional and National Development Sector, WIPO

Presentation

Session 2: Select Information Resources - (14.10 – 15.40)

Ms. Paulina Rivas Calderón

Market Research Officer, Supply Division, United Nations International Children's Emergency Fund, UNICEF

Presentation

Ms. Priya Basu

Head of Development Finance, World Bank Group

Presentation

Dr. Stefano Ongarello

Director of Data Science, FIND, The Global Alliance for Diagnostics

Presentation

Mr. Adrian Alonso Ruiz

Researcher and Project Manager, Graduate Institute/Global Health Centre Knowledge Portal

Presentation

Ms. Julia Barnes-Weise

Executive Director, Global Healthcare Innovation Alliance Accelerator, GHIAA

Presentation

Dr. Stacey Arnold

Subject Matter Expert, ClinicalTrials.gov Results Quality Control Team, National Center for Biotechnology Information NCBI, National Library of Medicine, National Institutes of Health in Bethesda

Presentation

Concluding Discussion with Participants - (15.50 – 16.20)

  • Practical considerations in accessing and using data
  • Identifying gaps
  • Maintaining the dialogue
  • Charting future needs for technical assistance and policy support

Closure - (16.20)


Share


Problems viewing this page? If so, please contact [email protected] giving details of the operating system and web browser you are using.